A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder
Clinical trial NCT05257265 · COMPLETED
Trial details
- NCT number
- NCT05257265
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-02
- Primary completion
- 2023-09-29
- Enrollment
- 459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.